Journal of Clinical Oncology

Vol. 44, Issue 16_suppl Issue 16_suppl 2026
7213
Articles

Articles in this Issue

Cerebrospinal fluid proteomics to identify biomarkers for the diagnosis and prediction of leptomeningeal metastasis from non–small cell lung cancer.

Zhimin Zeng Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e15009

e15009 Background: Leptomeningeal metastasis (LM), a terminal complication of non-small-cell lung cancer (NSCLC), lacks va...

Induction chemotherapy response–guided selection for hypoxia-directed major radiation de-escalation in T3–T4 HPV-positive oropharyngeal cancer.

Eric Jeffrey Sherman, Nadeem Riaz, Winston Wong et al. Jun 01, 2026 pp. 6103-6103 10.1200/jco.2026.44.16_suppl.6103

6103 Background: De-escalation trials in human papillomavirus associated oropharyngeal carcinoma (HPV+ OPC) often exclude...

Targeting the Warburg effect: Mitochondrial metabolic modulation with intermittent fasting during neoadjuvant chemoradiation in rectal cancer compared with standard neoadjuvant chemoradiation and total neoadjuvant therapy.

Krithikaa Sekar, Lohith Gopala Reddy, Basavalinga Sadasivaiah Ajaikumar et al. Jun 01, 2026 pp. 3612-3612 10.1200/jco.2026.44.16_suppl.3612

3612 Background: Cancer cells demonstrate metabolic inflexibility characterized by glycolytic dependence and dysfunctional...

Impact of sociodemographic factors on molecular testing patterns in localized and metastatic malignancies.

Breanna Collins, Harshitha Reddy Dudipala, Priyanka Naik et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e13510

e13510 Background: Next-generation sequencing (NGS) identifies actionable mutations that guide precision therapy in both l...

Epidemiological trends in colorectal cancer incidence, prevalence, and mortality burden in the United States, 1990–2023: Retrospective analysis and advanced machine learning forecasting to 2050.

Ibrahim Khalil, Nabila Nur, Anika Chowdhury et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e15588

e15588 Background: Colorectal cancer remains one of the leading causes of cancer incidence and mortality in the United Sta...

Inpatient mortality and length of stay associated with splanchnic vein thrombosis in gastrointestinal cancers: A National Inpatient Sample analysis.

Rishi Bothara, Eugene Annor, Li Liu et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e16335

e16335 Background: Splanchnic vein thrombosis (SVT) is a rare but serious complication in gastrointestinal (GI) cancer pat...

Body mass index and mortality in immune checkpoint inhibitor–treated cancers: A real-world propensity-matched analysis.

Katherin Zambrano, Antonio Arciniegas Rubio, Zeeshan Solangi et al. Jun 01, 2026 pp. 11069-11069 10.1200/jco.2026.44.16_suppl.11069

11069 Background: Immune checkpoint inhibitors (ICIs) are a cornerstone of treatment for multiple solid tumors, including...

Framing and availability of information regarding alternative cancer therapies by top U.S. cancer centers.

Nicholas Bever, Matt Gao, Nicholas James Hornstein et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e13713

e13713 Background: Patients with a cancer diagnosis increasingly encounter online claims promoting alternative treatment t...

UGT1A1 status and clinical outcomes in pancreatic cancer patients receiving liposomal irinotecan.

Ricardo David Espinosa, Shreya Condamoor, Joanna Yuen et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e16429

e16429 Background: Pancreatic cancer (PCa) is one of the most lethal malignancies with limited effective treatment options...

Patterns of care and long-term survival in metastasizing ameloblastoma: An NCDB study.

Dora Le, Madi Williams, Tyson Morris et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e18153

e18153 Background: Metastasizing ameloblastoma (MA) is diagnosed when a benign but aggressive ameloblastoma spreads to dis...

Updated results from a pilot trial of neoadjuvant durvalumb in combination with tremelimuab for cisplatin-ineligible high-risk urothelial carcinoma.

Cindy Y. Jiang, Neema Navai, Rebecca Slack Tidwell et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e16584

e16584 Background: We previously reported that neoadjuvant immune checkpoint therapy (ICT) with durvalumab (D) plus tremel...

Temporal trends in pregnancy-associated cancer mortality in the United States: A national analysis 2018-2023.

Diya Jayram, Ami Dave, Junzo P. Chino et al. Jun 01, 2026 pp. 11029-11029 10.1200/jco.2026.44.16_suppl.11029

11029 Background: Cancer during pregnancy is rare but increasing due to rising rates of early-onset cancers and more paren...

REINFORCE: A phase III randomized trial of treatment intensification with docetaxel in metastatic hormone-sensitive prostate cancer patients without deep PSA response after initial apalutamide therapy.

Enrique González-Billalabeitia, Romain Mathieu, Guilhem Roubaud et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.tps5147

TPS5147 Background: Androgen deprivation therapy (ADT) plus androgen receptor pathway inhibitors (ARPIs) is the standard o...

Consumer wearables and medical care utilization in gastrointestinal cancers: A Fitbit data analysis in NIH All of Us Research Program.

Osama Elkhider, Alisha Sharma Jun 01, 2026 pp. 11100-11100 10.1200/jco.2026.44.16_suppl.11100

11100 Background: Patients with gastrointestinal (GI) cancers may experience delayed or forgone care due to cost, travel,...

Improving cancer education and safety in rural communities through a digital literacy platform.

Joanna K. Metzner-Sadurski, Tracie Williamson, Jennifer Clary et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e23302

e23302 Background: Cancer care is increasingly complex, requiring patients to understand diagnoses, treatment options, sid...

A prospective study of the early treatment of recombinant human thrombopoietin for chemoradiation-induced thrombocytopenia in cervical squamous cell carcinoma patients.

Lu Li, Ming Fan, Yueqian Guo et al. Jun 01, 2026 pp. 12125-12125 10.1200/jco.2026.44.16_suppl.12125

12125 Background: To explore the early intervention timing of recombinant human thrombopoietin (rhTPO) for cancer treatmen...

Impact of targeted axillary dissection on axillary lymph node dissection rates compared with sentinel lymph node biopsy in cN1 breast cancer patients after neoadjuvant chemotherapy: A single-centre study.

Nashi Semitha Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e12675

e12675 Background: In clinically node positive (cN1) breast cancer patients post neoadjuvant chemotherapy (NACT), Axillary...

Clinical impact and temporal evolution of mutational signatures in metastatic lobular breast cancer.

Sherry Shen, Fresia Pareja, Lounes Djerroudi et al. Jun 01, 2026 pp. 1141-1141 10.1200/jco.2026.44.16_suppl.1141

1141 Background: Invasive lobular carcinoma (ILC) has distinct genomic features, including frequent CD...

Optimizing survivorship transitions utilizing an EHR visual alert.

Johnny Rollins, Angela Peek, Kamil Ciborowski et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e13508

e13508 Background: There is a large and growing population of cancer survivors at risk for chronic health conditions and s...

The real-world outcomes from late-line chemotherapy for advanced colorectal cancer: A population-based analysis of attrition rates, outcomes, and health care contact in a single-payer health system.

Brooke Wilson, Nan Chen, Arjun Gupta et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e23443

e23443 Background: Few population-level real-world studies have evaluated the uptake, health care contact time, and effica...

Mortality patterns and disparities in primary malignant brain neoplasms among U.S. adults aged ≥75 years: A 25-year retrospective analysis.

Sarim Hassan Shahab, Abubakar Nazir, Syeda Malika Naqvi et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e14064

e14064 Background: Primary malignant neoplasms of the brain disproportionately affect older adults, yet population-level m...

Long-term trends in pheochromocytoma in the United States, 1975–2022: A SEER-based study.

Deepak Raj, Madho Mal, Shiwani Keswani et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e22593

e22593 Background: Pheochromocytoma is a rare neuroendocrine tumor, and population-level data describing long-term tempora...

RT01: A first-in-class theranostic radionuclide drug conjugate (RDC) with zirconium-89 and lutetium-177 targeting tissue factor.

Zhican Qu, Yi Zhao, Jie Gao et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e15151

e15151 Background: Tissue factor (TF) is highly expressed in various solid tumors, including pancreatic, cervical, and lun...

Outcomes after single-fraction preoperative stereotactic radiosurgery for brain metastases: A systematic review and meta-analysis.

Ruchit Jain, Khalid Ahmad Qidwai, Fatma Nihan Akkoc Mustafayev et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e14016

e14016 Background: Postoperative stereotactic radiosurgery (SRS) is utilized following resection of brain metastases (BM),...

Impact of neoadjuvant immunotherapy on safety of axillary de-escalation in triple-negative breast cancer (TNBC): A propensity score–matched analysis.

Zheng Qu, Zheng Li, Hongzhe Zhang et al. Jun 01, 2026 10.1200/jco.2026.44.16_suppl.e12674

e12674 Background: While the addition of immune checkpoint inhibitors (ICIs) to neoadjuvant chemotherapy (NAC) has improve...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0732-183X
E-ISSN 1527-7755
Subject Health Sciences
Language English
View Full Journal Page